Smoking Status Effect on Inflammatory Markers in a Randomized Trial of Current and Former Heavy Smokers

International Journal of Inflammation

Volumn 2015, Issue , 2015, Pages

  Aldaham, Sami ^a   Foote, Janet A ^b   Chow, H H Sherry ^c   Hakim, Iman A ^b,c  

^a AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; C REACTIVE PROTEIN ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; PROTEIN ANTIBODY; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; SMOKING HABIT; SPECTROPHOTOMETRY; TEA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84941033953     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2015/439396     Document Type: Article

References (28)

1. M. Y. Abeywardena, W. R. Leifert, K. E.Warnes, J. N. Varghese, and R. J. Head, "Cardiovascular biology of interleukin-6, " Current Pharmaceutical Design, vol. 15, no. 15, pp. 1809-1821, 2009.
2. V. Pasceri, J. T.Willerson, and E. T. H. Yeh, "Direct proinflammatory effect of C-reactive protein on human endothelial cells, " Circulation, vol. 102, no. 18, pp. 2165-2168, 2000.
3. B. G. Nordestgaard and J. Zacho, "Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?" Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 8, pp. 521-524, 2009.
4. M. Ohsawa, A. Okayama, M. Nakamura et al., "CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers, " Preventive Medicine, vol. 41, no. 2, pp. 651-656, 2005.
5. R. Roubenoff, T. B. Harris, L.W. Abad, P. W. E. Wilson, G. E. Dallal, and C. A. Dinarello, "Monocyte cytokine production in an elderly population: effect of age and inflammation, " Journals of Gerontology-Series A Biological Sciences and Medical Sciences, vol. 53, no. 1, pp. M20-M26, 1998.
6. S. Cheng, A. Lyass, J. M. Massaro, G. T. O'Connor, J. F. Keaney Jr., and R. S. Vasan, "Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community, " Circulation, vol. 122, no. 15, pp. 1470-1477, 2010.
7. W. B. Ershler and E. T. Keller, "Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty, " Annual Review of Medicine, vol. 51, pp. 245-270, 2000.
8. J. A. Nettleton, L. M. Steffen, E. J.Mayer-Davis et al., "Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA), " American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1369-1379, 2006.
9. P. M. Ridker, N. Rifai, M. J. Stampfer, and C. H. Hennekens, "Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthymen, " Circulation, vol. 101, no. 15, pp. 1767-1772, 2000.
10. J. Danesh, R. Collins, P. Appleby, and R. Peto, "Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies, " Journal of the AmericanMedical Association, vol. 279, no. 18, pp. 1477-1482, 1998.
11. M. Miller, M. Zhan, and S. Havas, "High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the third National Health and Nutrition Examination Survey, " Archives of Internal Medicine, vol. 165, no. 18, pp. 2063-2068, 2005.
12. M. Groblewska, B.Mroczko, U.Wereszczyńska-Siemiaţkowska et al., "Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients, " Clinical Chemistry and Laboratory Medicine, vol. 46, no. 10, pp. 1423-1428, 2008.
13. M. Hara, Y. Matsuzaki, T. Shimuzu et al., "Preoperative serum C-reactive protein level in non-small cell lung cancer, " Anticancer Research, vol. 27, no. 4, pp. 3001-3004, 2008.
14. D.-K. Kim, S. Y. Oh, H.-C. Kwon et al., "Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer, "BMC Cancer, vol. 9, article 155, 2009.
15. J. Danesh, P.Whincup, M.Walker et al., "Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses, " British Medical Journal, vol. 321, no. 7255, pp. 199-204, 2000.
16. M. A. Mendall, D. P. Strachan, B. K. Butland et al., "C-reactive protein: relation to totalmortality, cardiovascularmortality and cardiovascular risk factors inmen, " EuropeanHeart Journal, vol. 21, no. 19, pp. 1584-1590, 2000.
17. M. Roivainen, M. Viik-Kajander, T. Palosuo et al., "Infections, inflammation, and the risk of coronary heart disease, " Circulation, vol. 101, no. 3, pp. 252-257, 2000.
18. D. G.Yanbaeva, M.A.Dentener, E. C. Creutzberg, G.Wesseling, and E. F. M.Wouters, "Systemic effects of smoking, " Chest, vol. 131, no. 5, pp. 1557-1566, 2007.
19. J. Helmersson, A. Larsson, B. Vessby, and S. Basu, "Active smoking and a history of smoking are associated with enhanced prostaglandin F2α, interleukin-6 and F2-isoprostane formation in elderlymen, " Atherosclerosis, vol. 181, no. 1, pp. 201-207, 2005.
20. S. G. Wannamethee, G. D. O. Lowe, A. G. Shaper, A. Rumley, L. Lennon, and P. H. Whincup, "Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease, " European Heart Journal, vol. 26, no. 17, pp. 1765-1773, 2005.
21. M. Fröhlich, M. Sund, H. Löwel, A. Imhof, A. Hoffmeister, and W. Koenig, "Independent association of various smoking characteristics with markers of systemic inflammation in men: results from a representative sample of the general population (MONICAAugsburg survey 1994/95), " EuropeanHeart Journal, vol. 24, no. 14, pp. 1365-1372, 2003.
22. L. Ferrucci, A. Corsi, F. Lauretani et al., "The origins of agerelated proinflammatory state, " Blood, vol. 105, no. 6, pp. 2294-2299, 2005.
23. T. B. Harris, L. Ferrucci, R. P. Tracy et al., "Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly, " American Journal ofMedicine, vol. 106, no. 5, pp. 506-512, 1999.
24. J. K. Lee, R. Bettencourt, D. Brenner, T.-A. Le, E. Barrett-Connor, and R. Loomba, "Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo Study, " PLoS ONE, vol. 7, no. 4, Article ID e34218, 2012.
25. US Department of Health and Human Services, How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, Ga, USA, 2010.
26. A. Asthana, H. M. Johnson, M. E. Piper, M. C. Fiore, T. B. Baker, and J. H. Stein, "Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers, " American Heart Journal, vol. 160, no. 3, pp. 458-463, 2010.
27. A. Festa, R. D'Agostino Jr., G. Howard, L. Mykkänen, R. P. Tracy, and S. M. Haffner, "Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS), " Circulation, vol. 102, no. 1, pp. 42-47, 2000.
28. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, "C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, " The New England Journal ofMedicine, vol. 342, no. 12, pp. 836-843, 2000.